Portal de Periódicos da CAPES

Hepatitis A Transmission by Factor IX Concentrates: Control by Severe Dry Heat Treatment at 80°C

1997; Wiley; Volume: 73; Issue: 3 Linguagem: Inglês

10.1046/j.1423-0410.2000.73301891.x

1423-0410

Peter L. Roberts, Peter A. Feldman,

Liver Disease and Transplantation

Vox SanguinisVolume 73, Issue 3 p. 189-190 Hepatitis A Transmission by Factor IX Concentrates: Control by Severe Dry Heat Treatment at 80°C Peter Roberts, Peter Roberts R & D Department, Bio Products Laboratory, Elstree, UKSearch for more papers by this authorPeter Feldman, Peter Feldman R & D Department, Bio Products Laboratory, Elstree, UKSearch for more papers by this author Peter Roberts, Peter Roberts R & D Department, Bio Products Laboratory, Elstree, UKSearch for more papers by this authorPeter Feldman, Peter Feldman R & D Department, Bio Products Laboratory, Elstree, UKSearch for more papers by this author First published: 30 April 2003 https://doi.org/10.1046/j.1423-0410.2000.73301891.xCitations: 1 Peter Roberts, R & D Department, Bio Products Laboratory, Elstree, Herts WD6 3BX (UK) AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Lawlor E, Graham S, Davidson F, Yap PL, Cunningham C, Daly H, Temperley IJ: Hepatitis A transmission by factor IX concentrates. Vox Sang 1996; 71: 126–128. 2 Center for Disease Control : Hepatitis A among persons with hemophilia who received clotting factor concentrate — US, September–December 1995. Morbid Mortality Weekly Rep 1996; 45: 29–32. 3 Winkelman L, Feldman PA, Evans DR: Severe heat treatment of lyophilised coagulation factors; in J-J Morgenthaler (ed): Virus Inactivation in Plasma Products. Curr Stud Hematol Blood Transfus. Basel , Karger, 1989, vol 56, pp 56–69. 4 Study Group of the UK Haemophilia Centre Directors : Effect of dry heating of coagulation factor concentrates at 80°C for 72 h on transmission of non-A, non-B hepatitis. Lancet 1988; ii: 814–816. 5 Hart HF, Hart WG, Crossley J, Perrie A-M, Wood DJ, John A, McOmish F: Effect of terminal (dry) heat treatment on non-enveloped viruses in coagulation factor concentrates. Vox Sang 1994; 67: 345–350. 6 Shapiro AD: New factor IX concentrates. Int J Pediatr Hematol/Oncol 1994; 1: 479–490. 7 Roberts PL, Walker CP, Feldman PA: Removal and inactivation of enveloped and non-enveloped viruses during the purification of a high-purity factor IX by metal chelate affinity chromatography. Vox Sang 1994; 67(suppl 1): 69–71. 8 Roberts PL: Removal of parvovirus and hepatitis A virus by metal chelate affinity chromatography during the preparation of Replenine: A high-purity factor IX concentrate. Vox Sang 1996; 71: 129–130. 9 Roberts PL: Value of virus filtration as a method for improving the safety of plasma products. Vox Sang 1995; 69: 82–83. 10 Crombie D, Bramall D, Winkelman L, Feldman P, Roberts P: Use of virusretentive filters in the preparation of coagulation factor concentrates. Thromb Haemost 1995; 73: 1023. Citing Literature Volume73, Issue3October 1997Pages 189-190 ReferencesRelatedInformation